questionsmedicales.fr
Disciplines et activités comportementales
Psychothérapie
Thérapie comportementale
Thérapie comportementale : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Thérapie comportementale : Questions médicales les plus fréquentes",
"headline": "Thérapie comportementale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Thérapie comportementale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-14",
"dateModified": "2025-03-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Thérapie comportementale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Psychothérapie",
"url": "https://questionsmedicales.fr/mesh/D011613",
"about": {
"@type": "MedicalCondition",
"name": "Psychothérapie",
"code": {
"@type": "MedicalCode",
"code": "D011613",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thérapie de maitrise de la colère",
"alternateName": "Anger Management Therapy",
"url": "https://questionsmedicales.fr/mesh/D000067449",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie de maitrise de la colère",
"code": {
"@type": "MedicalCode",
"code": "D000067449",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.087"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Analyse comportementale appliquée",
"alternateName": "Applied Behavior Analysis",
"url": "https://questionsmedicales.fr/mesh/D000072357",
"about": {
"@type": "MedicalCondition",
"name": "Analyse comportementale appliquée",
"code": {
"@type": "MedicalCode",
"code": "D000072357",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.131"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thérapie aversive",
"alternateName": "Aversive Therapy",
"url": "https://questionsmedicales.fr/mesh/D001348",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie aversive",
"code": {
"@type": "MedicalCode",
"code": "D001348",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.174"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thérapie cognitive",
"alternateName": "Cognitive Behavioral Therapy",
"url": "https://questionsmedicales.fr/mesh/D015928",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie cognitive",
"code": {
"@type": "MedicalCode",
"code": "D015928",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.350"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thérapie d'acceptation et d'engagement",
"alternateName": "Acceptance and Commitment Therapy",
"url": "https://questionsmedicales.fr/mesh/D064869",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie d'acceptation et d'engagement",
"code": {
"@type": "MedicalCode",
"code": "D064869",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.350.249"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Restructuration cognitive",
"alternateName": "Cognitive Restructuring",
"url": "https://questionsmedicales.fr/mesh/D000088686",
"about": {
"@type": "MedicalCondition",
"name": "Restructuration cognitive",
"code": {
"@type": "MedicalCode",
"code": "D000088686",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.350.375"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Pleine conscience",
"alternateName": "Mindfulness",
"url": "https://questionsmedicales.fr/mesh/D064866",
"about": {
"@type": "MedicalCondition",
"name": "Pleine conscience",
"code": {
"@type": "MedicalCode",
"code": "D064866",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.350.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Remédiation cognitive",
"alternateName": "Cognitive Remediation",
"url": "https://questionsmedicales.fr/mesh/D000072466",
"about": {
"@type": "MedicalCondition",
"name": "Remédiation cognitive",
"code": {
"@type": "MedicalCode",
"code": "D000072466",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.365"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Désensibilisation psychologique",
"alternateName": "Desensitization, Psychologic",
"url": "https://questionsmedicales.fr/mesh/D003887",
"about": {
"@type": "MedicalCondition",
"name": "Désensibilisation psychologique",
"code": {
"@type": "MedicalCode",
"code": "D003887",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.506"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Désensibilisation et reprogrammation par mouvements oculaires",
"alternateName": "Eye Movement Desensitization Reprocessing",
"url": "https://questionsmedicales.fr/mesh/D057169",
"about": {
"@type": "MedicalCondition",
"name": "Désensibilisation et reprogrammation par mouvements oculaires",
"code": {
"@type": "MedicalCode",
"code": "D057169",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.506.162"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thérapie implosive",
"alternateName": "Implosive Therapy",
"url": "https://questionsmedicales.fr/mesh/D007171",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie implosive",
"code": {
"@type": "MedicalCode",
"code": "D007171",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.506.325"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thérapie par réalité virtuelle",
"alternateName": "Virtual Reality Exposure Therapy",
"url": "https://questionsmedicales.fr/mesh/D063367",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie par réalité virtuelle",
"code": {
"@type": "MedicalCode",
"code": "D063367",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.506.662"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Thérapie comportementale dialectique",
"alternateName": "Dialectical Behavior Therapy",
"url": "https://questionsmedicales.fr/mesh/D000077252",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie comportementale dialectique",
"code": {
"@type": "MedicalCode",
"code": "D000077252",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.628"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thérapie par la relaxation",
"alternateName": "Relaxation Therapy",
"url": "https://questionsmedicales.fr/mesh/D012064",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie par la relaxation",
"code": {
"@type": "MedicalCode",
"code": "D012064",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.750"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Méditation",
"alternateName": "Meditation",
"url": "https://questionsmedicales.fr/mesh/D019122",
"about": {
"@type": "MedicalCondition",
"name": "Méditation",
"code": {
"@type": "MedicalCode",
"code": "D019122",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.750.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Chronothérapie sur les phases de sommeil",
"alternateName": "Sleep Phase Chronotherapy",
"url": "https://questionsmedicales.fr/mesh/D055865",
"about": {
"@type": "MedicalCondition",
"name": "Chronothérapie sur les phases de sommeil",
"code": {
"@type": "MedicalCode",
"code": "D055865",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.875"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Thérapie comportementale",
"alternateName": "Behavior Therapy",
"code": {
"@type": "MedicalCode",
"code": "D001521",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Daniel F Gros",
"url": "https://questionsmedicales.fr/author/Daniel%20F%20Gros",
"affiliation": {
"@type": "Organization",
"name": "Mental Health Service, Ralph H. Johnson VA Healthcare System, Charleston, South Carolina, USA."
}
},
{
"@type": "Person",
"name": "Tanja van der Zweerde",
"url": "https://questionsmedicales.fr/author/Tanja%20van%20der%20Zweerde",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Psychology, EMGO Institute for Health and Care Research, VU University, Van der Boechorststraat 7, Amsterdam 1081 BT, the Netherlands. Electronic address: t.vander.zweerde@vu.nl."
}
},
{
"@type": "Person",
"name": "Jaap Lancee",
"url": "https://questionsmedicales.fr/author/Jaap%20Lancee",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Psychology, University of Amsterdam, Nieuwe Achtergracht 129, Amsterdam 1018 WS, the Netherlands; PsyQ Amsterdam, Amsterdam, the Netherlands."
}
},
{
"@type": "Person",
"name": "Annemieke van Straten",
"url": "https://questionsmedicales.fr/author/Annemieke%20van%20Straten",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Psychology, EMGO Institute for Health and Care Research, VU University, Van der Boechorststraat 7, Amsterdam 1081 BT, the Netherlands."
}
},
{
"@type": "Person",
"name": "Shireen L Rizvi",
"url": "https://questionsmedicales.fr/author/Shireen%20L%20Rizvi",
"affiliation": {
"@type": "Organization",
"name": "Rutgers University. Electronic address: slrizvi@gsapp.rutgers.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Smoking Cessation May Reduce Risk of Visual Field Progression in Heavy Smokers.",
"datePublished": "2022-08-02",
"url": "https://questionsmedicales.fr/article/35939832",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/IJG.0000000000002092"
}
},
{
"@type": "ScholarlyArticle",
"name": "Correlation between Interocular Asymmetry of Corneal Hysteresis and Visual Field Defect in Glaucoma.",
"datePublished": "2023-02-09",
"url": "https://questionsmedicales.fr/article/36758563",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3341/kjo.2022.0120"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparing the Accuracy of Peripapillary OCT Scans and Visual Fields to Detect Glaucoma Worsening.",
"datePublished": "2023-02-06",
"url": "https://questionsmedicales.fr/article/36754173",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ophtha.2023.01.021"
}
},
{
"@type": "ScholarlyArticle",
"name": "Two-Year Visual Field Outcomes of the Treatment of Advanced Glaucoma Study (TAGS).",
"datePublished": "2022-10-10",
"url": "https://questionsmedicales.fr/article/36228777",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ajo.2022.09.011"
}
},
{
"@type": "ScholarlyArticle",
"name": "Visual Field Endpoints for Neuroprotective Trials: A Case for AI-Driven Patient Enrichment.",
"datePublished": "2022-07-28",
"url": "https://questionsmedicales.fr/article/35907473",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ajo.2022.07.013"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Disciplines et activités comportementales",
"item": "https://questionsmedicales.fr/mesh/D004191"
},
{
"@type": "ListItem",
"position": 3,
"name": "Psychothérapie",
"item": "https://questionsmedicales.fr/mesh/D011613"
},
{
"@type": "ListItem",
"position": 4,
"name": "Thérapie comportementale",
"item": "https://questionsmedicales.fr/mesh/D001521"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Thérapie comportementale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Thérapie comportementale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Thérapie comportementale",
"description": "Comment diagnostiquer un besoin de thérapie comportementale ?\nQuels tests sont utilisés pour le diagnostic ?\nQui peut poser un diagnostic pour cette thérapie ?\nQuels critères sont utilisés pour le diagnostic ?\nLa thérapie comportementale est-elle adaptée à tous ?",
"url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Visual+Field+Tests&page=4#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Thérapie comportementale",
"description": "Quels symptômes indiquent un besoin de thérapie comportementale ?\nComment les symptômes varient-ils selon les individus ?\nLes symptômes physiques sont-ils liés à la thérapie comportementale ?\nLes symptômes peuvent-ils s'aggraver sans traitement ?\nQuels sont les signes d'amélioration avec la thérapie ?",
"url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Visual+Field+Tests&page=4#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Thérapie comportementale",
"description": "Comment prévenir les troubles nécessitant une thérapie comportementale ?\nLes programmes scolaires peuvent-ils aider à la prévention ?\nQuels rôles jouent les parents dans la prévention ?\nLa prévention est-elle possible à l'âge adulte ?\nLes groupes de soutien peuvent-ils aider à la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Visual+Field+Tests&page=4#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Thérapie comportementale",
"description": "Quelles techniques sont utilisées en thérapie comportementale ?\nCombien de séances sont généralement nécessaires ?\nLa thérapie comportementale peut-elle être combinée avec d'autres traitements ?\nQuels sont les objectifs principaux de cette thérapie ?\nLa thérapie comportementale est-elle efficace pour les enfants ?",
"url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Visual+Field+Tests&page=4#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Thérapie comportementale",
"description": "Quelles complications peuvent survenir sans traitement ?\nLa thérapie comportementale peut-elle entraîner des effets secondaires ?\nQuels risques de rechute existent après la thérapie ?\nLes complications psychologiques peuvent-elles affecter la santé physique ?\nComment minimiser les complications après la thérapie ?",
"url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Visual+Field+Tests&page=4#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Thérapie comportementale",
"description": "Quels facteurs augmentent le risque de troubles comportementaux ?\nL'environnement familial influence-t-il les comportements ?\nLes antécédents médicaux jouent-ils un rôle ?\nLe manque de soutien social est-il un facteur de risque ?\nLes événements de vie stressants augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D001521?mesh_terms=Visual+Field+Tests&page=4#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un besoin de thérapie comportementale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un professionnel évalue les comportements problématiques et leur impact sur la vie quotidienne."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des questionnaires et des entretiens cliniques sont souvent utilisés pour évaluer les comportements."
}
},
{
"@type": "Question",
"name": "Qui peut poser un diagnostic pour cette thérapie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un psychologue, un psychiatre ou un thérapeute qualifié peut poser ce diagnostic."
}
},
{
"@type": "Question",
"name": "Quels critères sont utilisés pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent la fréquence, l'intensité et l'impact des comportements sur la vie."
}
},
{
"@type": "Question",
"name": "La thérapie comportementale est-elle adaptée à tous ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est efficace pour de nombreux troubles, mais un diagnostic précis est essentiel."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un besoin de thérapie comportementale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des comportements compulsifs, des phobies ou des troubles d'anxiété peuvent indiquer ce besoin."
}
},
{
"@type": "Question",
"name": "Comment les symptômes varient-ils selon les individus ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent varier en intensité et en type selon les expériences personnelles."
}
},
{
"@type": "Question",
"name": "Les symptômes physiques sont-ils liés à la thérapie comportementale ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes physiques comme des palpitations peuvent accompagner des troubles psychologiques."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils s'aggraver sans traitement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sans traitement, les symptômes peuvent s'intensifier et affecter la qualité de vie."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'amélioration avec la thérapie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une réduction des comportements problématiques et une meilleure gestion des émotions sont des signes."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles nécessitant une thérapie comportementale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par l'éducation émotionnelle et le développement de compétences sociales dès le jeune âge."
}
},
{
"@type": "Question",
"name": "Les programmes scolaires peuvent-ils aider à la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des programmes de sensibilisation et de gestion des émotions dans les écoles peuvent être bénéfiques."
}
},
{
"@type": "Question",
"name": "Quels rôles jouent les parents dans la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les parents peuvent enseigner des stratégies de gestion du stress et des comportements positifs à leurs enfants."
}
},
{
"@type": "Question",
"name": "La prévention est-elle possible à l'âge adulte ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des techniques de gestion du stress et de résolution de problèmes peuvent prévenir l'apparition de troubles."
}
},
{
"@type": "Question",
"name": "Les groupes de soutien peuvent-ils aider à la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les groupes de soutien offrent un espace pour partager des expériences et apprendre des stratégies de prévention."
}
},
{
"@type": "Question",
"name": "Quelles techniques sont utilisées en thérapie comportementale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques comme le conditionnement opérant, l'exposition et la restructuration cognitive sont courantes."
}
},
{
"@type": "Question",
"name": "Combien de séances sont généralement nécessaires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le nombre de séances varie, mais 10 à 20 séances sont souvent recommandées pour des résultats significatifs."
}
},
{
"@type": "Question",
"name": "La thérapie comportementale peut-elle être combinée avec d'autres traitements ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est souvent combinée avec des médicaments ou d'autres formes de thérapie pour une efficacité accrue."
}
},
{
"@type": "Question",
"name": "Quels sont les objectifs principaux de cette thérapie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les objectifs incluent la modification des comportements inadaptés et l'amélioration des compétences d'adaptation."
}
},
{
"@type": "Question",
"name": "La thérapie comportementale est-elle efficace pour les enfants ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est souvent utilisée pour traiter des troubles chez les enfants, comme l'anxiété et les phobies."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir sans traitement ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Sans traitement, les troubles peuvent s'aggraver, entraînant des problèmes relationnels et professionnels."
}
},
{
"@type": "Question",
"name": "La thérapie comportementale peut-elle entraîner des effets secondaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Généralement, elle n'a pas d'effets secondaires physiques, mais des émotions intenses peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels risques de rechute existent après la thérapie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des rechutes peuvent survenir si les compétences acquises ne sont pas pratiquées régulièrement."
}
},
{
"@type": "Question",
"name": "Les complications psychologiques peuvent-elles affecter la santé physique ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles psychologiques non traités peuvent entraîner des problèmes de santé physique, comme des maladies cardiaques."
}
},
{
"@type": "Question",
"name": "Comment minimiser les complications après la thérapie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La pratique continue des compétences apprises et le soutien social aident à minimiser les complications."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de troubles comportementaux ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme le stress, l'hérédité et des événements traumatiques augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'environnement familial influence-t-il les comportements ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un environnement familial instable ou conflictuel peut contribuer au développement de troubles."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de troubles mentaux dans la famille peuvent augmenter le risque de troubles comportementaux."
}
},
{
"@type": "Question",
"name": "Le manque de soutien social est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un manque de soutien social peut exacerber les troubles et rendre la gestion plus difficile."
}
},
{
"@type": "Question",
"name": "Les événements de vie stressants augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des événements comme un divorce ou la perte d'un emploi peuvent déclencher des troubles comportementaux."
}
}
]
}
]
}
The earlier a person quits smoking the more likely is the optic nerve be spared from damage....
To investigate the effect of smoking cessation on visual field (VF) progression in glaucoma....
Primary open angle glaucoma patients with a minimum of 3 years follow-up and 5 VFs were included. Linear mixed models were used to investigate the effects of smoking on the rates of 24-2 VF mean devia...
Five hundred eleven eyes of 354 patients were included over the mean follow-up of 12.4 years. Mean baseline age (95% confidence interval) was 62.3 (61.2, 63.4) years. One hundred forty nine (42.1%) pa...
After ≥25 years of smoking cessation, the risk of VF progression in former heavy smokers becomes similar to never smokers. Long-term smoking cessation may be associated with lower VF progression in gl...
To evaluate the relationship between interocular asymmetries of corneal hysteresis (CH) and visual field defects in Korean patients with glaucoma....
A total of 444 eyes from 222 participants with glaucoma in at least one eye were enrolled. CH was measured using an ocular response analyzer (Reichert Technologies Inc). Eyes of each participant were ...
Median (interquartile range) MD value was -3.71 dB (-6.87 to -1.30 dB) in the better eye and -10.20 dB (-16.32 to -5.62 dB) in the worse eye. When the correlation between the asymmetry of the MD value...
The interocular asymmetry of CH was significantly correlated with the interocular asymmetry of visual field defects in glaucoma....
To compare the accuracy of detecting moderate and rapid rates of glaucoma worsening over a 2-year period with different numbers of OCT scans and visual field (VF) tests in a large sample of glaucoma a...
Descriptive and simulation study....
The OCT sample comprised 12 150 eyes from 7392 adults with glaucoma or glaucoma suspect status followed up at the Wilmer Eye Institute from 2013 through 2021. The VF sample comprised 20 583 eyes from ...
Within-eye rates of change in retinal nerve fiber layer (RNFL) thickness and mean deviation (MD) were measured using linear regression. For each measured rate, simulated measurements of RNFL thickness...
The accuracy of diagnosing moderate and rapid rates of glaucoma worsening for different numbers of OCT scans and VF tests over a 2-year period....
Accuracy was less than 50% for both OCT and VF when diagnosing worsening after a 2-year period. OCT accuracy was 5 to 10 percentage points higher than VF accuracy at detecting moderate worsening and 1...
More frequent OCT scans and VF tests are needed to improve the accuracy of diagnosing glaucoma worsening. Accuracy greatly increases when relying on both OCT and VF to detect worsening....
The author(s) have no proprietary or commercial interest in any materials discussed in this article....
to compare visual field (VF) progression between the 2 arms of the Treatment of Advanced Glaucoma Study (TAGS)....
Post hoc analysis of VF data from a 2-arm, multicenter, randomized controlled clinical trial....
A total of 453 patients with newly diagnosed advanced open-angle glaucoma in at least 1 eye from 27 centers in the United Kingdom were randomized to either trabeculectomy (n = 227) or medication in th...
This study analyzed 211 eyes in the trabeculectomy first arm and 203 eyes in the medication first arm. The average RoP (estimate [95% credible intervals]) was -0.59 [-0.88, -0.31] dB/year in the medic...
There was no significant difference in the average RoP at 2 years....
To evaluate whether an artificial intelligence (AI) model can better select candidates that would demonstrate visual field (VF) progression, in order to shorten the duration or the number of patients ...
Retrospective cohort study....
7428 eyes of 3871 patients from the University of Washington Department of Ophthalmology VF Dataset were included. Progression was defined as at least 5 locations with >7 dB of change compared with ba...
A total of 13% of all patients met the criteria for progression at 5 years. Differences in survival were observed when stratified by MD and age (P < .0001). Those at risk of progression included patie...
An AI model can identify high-risk patients to substantially reduce the number of patients needed or study duration required to meet clinical trial endpoints....
To determine the prevalence of fast global and central visual field (VF) progression in individuals with glaucoma under routine care....
Observational study....
Six hundred ninety-three eyes of 461 individuals with glaucoma followed up over a median of 4.5 years....
This study included (1) patients at a private ophthalmology clinic in Melbourne, Australia, and (2) individuals in 2 prospective longitudinal observational studies across 3 sites in the United States....
Prevalence of progression based on the rate of MD and the MTD...
Based on the MD and the MTD...
This study found that approximately 1 in 8 eyes with glaucoma receiving routine care showed fast progression based on global MD values (< -1.0 dB/year) and that nearly 1 in 3 eyes showed a < -0.5 dB/y...
Proprietary or commercial disclosure may be found after the references....
In this study, we investigated the patterns of visual field (VF) defects and the diagnostic abilities of VF tests using different strategies in Asian patients with hydroxychloroquine retinopathy. Pati...
The representation of the visual field in visual cortex was established over a century ago by correlating perimetric defects with the estimated location of war wounds. The availability of high-definit...
Homonymous hemianopias disclosed on automated visual fields (HVFs) were drawn from an electronic medical record search from 2009 to 2020 at the Michigan Medicine, a tertiary care academic medical cent...
Among the 77 VFDs confined to 1 hemifield, 74 (96%) correctly predicted the side of the visual cortex lesion. In 3 cases, the MRI lesion in the opposite cerebral hemisphere was not foretold. Among the...
In this study of PCA ischemic stroke, VFDs limited to 1 hemifield were accurate in locating the side and quadrant of the MRI visual cortex lesions. However, the quadrantic VFDs sometimes failed to pre...
Presence of baseline 10-2 visual field (VF) loss was the strongest predictor of future rate of 24-2 VF loss and development of new 24-2 progression events, suggesting a role for 10-2 VF testing in bas...
The purpose of this study is to examine the relationship between baseline 10-2 VF loss and future 24-2 VF loss....
Subjects were participating in a prospective longitudinal study within a VA Medical Center outpatient eye clinic. Eligibility required 2 good quality baseline 10-2 VF tests followed by a minimum of 5 ...
We studied 394 eyes of 202 subjects (119 primary open angle glaucoma and 83 glaucoma suspect). Over 6.7 (±1.5) years, 9.9 (±2.3) good quality 24-2 VF tests were completed. In mixed model regression an...
Baseline 10-2 VF defect was the most effective predictor of subsequent 24-2 VF progression in this study. These findings imply that presence of baseline 10-2 VF loss may provide unique value for predi...
In visual rehabilitation, ground visual field assessment (GVFA) makes it possible to assess the size of scotomas in connection with locomotion and to restore the width of the patient's visual field (V...